Laura McCandless
Wed, July 1, 2026 astatine 12:20 PM CDT 1 min read
According to Schaeffer's Senior Quantitative Analyst Rocky White, XOM is trading wrong 0.75 times the 200-day moving average's 20-day mean existent scope (ATR), aft spending astatine slightest 80% of the erstwhile 2 weeks and 80% of the anterior 42 trading sessions supra that trendline. This setup has appeared 12 times implicit the past decade, aft which the banal was higher 1 period aboriginal 87% of the time, averaging a 5.3% gain.
A akin determination from the stock's existent perch would person it trading astatine $144.19 -- a portion that provided enactment from April to aboriginal June. Furthermore, XOM's 14-day comparative spot scale (RSI) of 27.5 sits successful "oversold" territory, which often precedes a short-term bounce.

3 hours ago
3





English (CA) ·
English (US) ·
Spanish (MX) ·